Bailard’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
3,214
+1,421
| +79% | +$553K | 0.03% | 297 |
|
|
2025
Q1 | $780K | Buy |
1,793
+116
| +7% | +$50.5K | 0.02% | 348 |
|
|
2024
Q4 | $619K | Sell |
1,677
-4,609
| -73% | -$1.7M | 0.02% | 422 |
|
|
2024
Q3 | $3.27M | Buy |
6,286
+129
| +2% | +$67.1K | 0.09% | 186 |
|
|
2024
Q2 | $3.34M | Sell |
6,157
-95
| -2% | -$51.5K | 0.09% | 173 |
|
|
2024
Q1 | $3.24M | Sell |
6,252
-488
| -7% | -$253K | 0.09% | 181 |
|
|
2023
Q4 | $3.18M | Buy |
6,740
+173
| +3% | +$81.6K | 0.09% | 177 |
|
|
2023
Q3 | $2.86M | Sell |
6,567
-10
| -0.2% | -$4.35K | 0.09% | 174 |
|
|
2023
Q2 | $2.92M | Sell |
6,577
-4,956
| -43% | -$2.2M | 0.1% | 157 |
|
|
2023
Q1 | $5.3M | Buy |
11,533
+20
| +0.2% | +$9.2K | 0.19% | 109 |
|
|
2022
Q4 | $5.91M | Sell |
11,513
-122
| -1% | -$62.6K | 0.23% | 98 |
|
|
2022
Q3 | $5.29M | Buy |
11,635
+1,080
| +10% | +$491K | 0.22% | 102 |
|
|
2022
Q2 | $5.09M | Sell |
10,555
-309
| -3% | -$149K | 0.2% | 106 |
|
|
2022
Q1 | $5.34M | Buy |
10,864
+36
| +0.3% | +$17.7K | 0.18% | 110 |
|
|
2021
Q4 | $5.02M | Hold |
10,828
| – | – | 0.16% | 122 |
|
|
2021
Q3 | $4.04M | Buy |
10,828
+54
| +0.5% | +$20.1K | 0.14% | 140 |
|
|
2021
Q2 | $4.11M | Sell |
10,774
-1,155
| -10% | -$441K | 0.14% | 139 |
|
|
2021
Q1 | $4.28M | Buy |
+11,929
| New | +$4.28M | 0.16% | 124 |
|
|
2015
Q4 | – | Sell |
-19,791
| Closed | -$2.77M | – | 247 |
|
|
2015
Q3 | $2.77M | Buy |
19,791
+705
| +4% | +$98.7K | 0.43% | 35 |
|
|
2015
Q2 | $3.13M | Buy |
19,086
+400
| +2% | +$65.7K | 0.48% | 33 |
|
|
2015
Q1 | $2.89M | Buy |
18,686
+134
| +0.7% | +$20.7K | 0.4% | 37 |
|
|
2014
Q4 | $2.33M | Buy |
18,552
+147
| +0.8% | +$18.5K | 0.33% | 49 |
|
|
2014
Q3 | $2.2M | Buy |
18,405
+168
| +0.9% | +$20.1K | 0.34% | 47 |
|
|
2014
Q2 | $1.96M | Buy |
+18,237
| New | +$1.96M | 0.3% | 58 |
|